Gene · 1033
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and Laboratory Characteristics of IgM Primary Plasma Cell Leukemia. | Clin Lab | 2023 | 37436385 | PubTator, text mining | PubMed |
| Psoriasis Associated Hub Genes Revealed by Weighted Gene Co-Expression Network Analysis. | Cell J | 2023 | 37434459 | PubTator, text mining | PubMed |
| Short-chain fatty acids in cancer pathogenesis. | Cancer Metastasis Rev | 2023 | 37432606 | PubTator, text mining | PubMed |
| A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers. | Discov Oncol | 2023 | 37432583 | PubTator, text mining | PubMed |
| MYC overrides HIF-1α to regulate proliferating primary cell metabolism in hypoxia. | Elife | 2023 | 37428010 | PubTator, text mining | PubMed |
| Comprehensive analysis of ferroptosis-related hub gene signatures as a potential pathogenesis and therapeutic target for systemic sclerosis: A bioinformatics analysis. | Int J Immunopathol Pharmacol | 2023 | 37403234 | PubTator, text mining | PubMed |
| FET fusion oncoproteins disrupt physiologic DNA repair networks and induce ATR synthetic lethality in cancer. | Res Sq | 2023 | 37398210 | PubTator, text mining | PubMed |
| Paraptosis: a unique cell death mode for targeting cancer. | Front Pharmacol | 2023 | 37397502 | PubTator, text mining | PubMed |
| Drivers of household antibiotic use in urban informal settlements in Northern Ghana: Implications for antimicrobial resistance control. | Health Sci Rep | 2023 | 37396564 | PubTator, text mining | PubMed |
| Modulation of SIRT6 activity acts as an emerging therapeutic implication for pathological disorders in the skeletal system. | Genes Dis | 2023 | 37396554 | PubTator, text mining | PubMed |
| A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification. | Infect Agent Cancer | 2023 | 37393234 | PubTator, text mining | PubMed |
| CHMP4C as a novel marker regulates prostate cancer progression through cycle pathways and contributes to immunotherapy. | Front Oncol | 2023 | 37388224 | PubTator, text mining | PubMed |
| Malignant melanoma resection and reconstruction with the first manifestation of lumbar metastasis: A case report. | World J Clin Cases | 2023 | 37383908 | PubTator, text mining | PubMed |
| TP53RK Drives the Progression of Chronic Kidney Disease by Phosphorylating Birc5. | Adv Sci (Weinh) | 2023 | 37382161 | PubTator, text mining | PubMed |
| The Roles of Zinc Finger Proteins in Colorectal Cancer. | Int J Mol Sci | 2023 | 37373394 | PubTator, text mining | PubMed |
| Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery. | Front Oncol | 2023 | 37361569 | PubTator, text mining | PubMed |
| Natural products modulate cell apoptosis: a promising way for treating endometrial cancer. | Front Pharmacol | 2023 | 37361222 | PubTator, text mining | PubMed |
| Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses. | Cell Rep | 2023 | 37355988 | PubTator, text mining | PubMed |
| MTX-13, a Novel PTK7-Directed Antibody-Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors. | Mol Cancer Ther | 2023 | 37352387 | PubTator, text mining | PubMed |
| A multiethnic genome-wide analysis of 19,420 individuals identifies novel loci associated with axial length and shared genetic influences with refractive error and myopia. | Front Genet | 2023 | 37351342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1033/papers?page=19